331 related articles for article (PubMed ID: 15703409)
21. The role of the gap junction protein connexin32 in the pathogenesis of X-linked Charcot-Marie-Tooth disease.
Scherer SS; Bone LJ; Deschênes SM; Abel A; Balice-Gordon RJ; Fischbeck KH
Novartis Found Symp; 1999; 219():175-85; discussion 185-7. PubMed ID: 10207904
[TBL] [Abstract][Full Text] [Related]
22. X-linked Charcot-Marie-Tooth disease and connexin32.
Fischbeck KH; Abel A; Lin GS; Scherer SS
Ann N Y Acad Sci; 1999 Sep; 883():36-41. PubMed ID: 10586227
[TBL] [Abstract][Full Text] [Related]
23. Connexin32 mutations cause loss of function in Schwann cells and oligodendrocytes leading to PNS and CNS myelination defects.
Sargiannidou I; Vavlitou N; Aristodemou S; Hadjisavvas A; Kyriacou K; Scherer SS; Kleopa KA
J Neurosci; 2009 Apr; 29(15):4736-49. PubMed ID: 19369543
[TBL] [Abstract][Full Text] [Related]
24. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients.
Hattori N; Yamamoto M; Yoshihara T; Koike H; Nakagawa M; Yoshikawa H; Ohnishi A; Hayasaka K; Onodera O; Baba M; Yasuda H; Saito T; Nakashima K; Kira J; Kaji R; Oka N; Sobue G;
Brain; 2003 Jan; 126(Pt 1):134-51. PubMed ID: 12477701
[TBL] [Abstract][Full Text] [Related]
25. Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.
Niemann A; Berger P; Suter U
Neuromolecular Med; 2006; 8(1-2):217-42. PubMed ID: 16775378
[TBL] [Abstract][Full Text] [Related]
26. Two new mouse models of Gjb1-associated Charcot-Marie-Tooth disease type 1X.
Tadenev ALD; Hatton CL; Pattavina B; Mullins T; Schneider R; Bogdanik LP; Burgess RW
J Peripher Nerv Syst; 2023 Sep; 28(3):317-328. PubMed ID: 37551045
[TBL] [Abstract][Full Text] [Related]
27. Intrathecal gene therapy rescues a model of demyelinating peripheral neuropathy.
Kagiava A; Sargiannidou I; Theophilidis G; Karaiskos C; Richter J; Bashiardes S; Schiza N; Nearchou M; Christodoulou C; Scherer SS; Kleopa KA
Proc Natl Acad Sci U S A; 2016 Apr; 113(17):E2421-9. PubMed ID: 27035961
[TBL] [Abstract][Full Text] [Related]
28. Gap junction disorders of myelinating cells.
Kleopa KA; Orthmann-Murphy J; Sargiannidou I
Rev Neurosci; 2010; 21(5):397-419. PubMed ID: 21280457
[TBL] [Abstract][Full Text] [Related]
29. X-linked Charcot-Marie-Tooth disease.
Scherer SS; Kleopa KA
J Peripher Nerv Syst; 2012 Dec; 17 Suppl 3(0 3):9-13. PubMed ID: 23279425
[TBL] [Abstract][Full Text] [Related]
30. Nonuniform molecular features of myelinating Schwann cells in models for CMT1: distinct disease patterns are associated with NCAM and c-Jun upregulation.
Klein D; Groh J; Wettmarshausen J; Martini R
Glia; 2014 May; 62(5):736-50. PubMed ID: 24526449
[TBL] [Abstract][Full Text] [Related]
31. CSF-1-activated macrophages are target-directed and essential mediators of Schwann cell dedifferentiation and dysfunction in Cx32-deficient mice.
Groh J; Klein I; Hollmann C; Wettmarshausen J; Klein D; Martini R
Glia; 2015 Jun; 63(6):977-86. PubMed ID: 25628221
[TBL] [Abstract][Full Text] [Related]
32. Connexin32 is a myelin-related protein in the PNS and CNS.
Scherer SS; Deschênes SM; Xu YT; Grinspan JB; Fischbeck KH; Paul DL
J Neurosci; 1995 Dec; 15(12):8281-94. PubMed ID: 8613761
[TBL] [Abstract][Full Text] [Related]
33. Connexin29 is uniquely distributed within myelinating glial cells of the central and peripheral nervous systems.
Altevogt BM; Kleopa KA; Postma FR; Scherer SS; Paul DL
J Neurosci; 2002 Aug; 22(15):6458-70. PubMed ID: 12151525
[TBL] [Abstract][Full Text] [Related]
34. Aberrant trafficking of a Leu89Pro connexin32 mutant associated with X-linked dominant Charcot-Marie-Tooth disease.
Da Y; Wang W; Liu Z; Chen H; Di L; Previch L; Chen Z
Neurol Res; 2016 Oct; 38(10):897-902. PubMed ID: 27367520
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms of gap junction mutations in myelinating cells.
Sargiannidou I; Markoullis K; Kleopa KA
Histol Histopathol; 2010 Sep; 25(9):1191-206. PubMed ID: 20607661
[TBL] [Abstract][Full Text] [Related]
36. Connexin32 gene expression in rat sciatic nerves and cultured Schwann cells.
Satake M; Yoshimura T; Ohnishi A; Kobayashi T
Dev Neurosci; 1997; 19(2):189-95. PubMed ID: 9097034
[TBL] [Abstract][Full Text] [Related]
37. Phenotypic and cellular expression of two novel connexin32 mutations causing CMT1X.
Kleopa KA; Zamba-Papanicolaou E; Alevra X; Nicolaou P; Georgiou DM; Hadjisavvas A; Kyriakides T; Christodoulou K
Neurology; 2006 Feb; 66(3):396-402. PubMed ID: 16476939
[TBL] [Abstract][Full Text] [Related]
38. Mutations of connexin32 in Charcot-Marie-Tooth disease type X interfere with cell-to-cell communication but not cell proliferation and myelin-specific gene expression.
Yoshimura T; Satake M; Ohnishi A; Tsutsumi Y; Fujikura Y
J Neurosci Res; 1998 Jan; 51(2):154-61. PubMed ID: 9469569
[TBL] [Abstract][Full Text] [Related]
39. Accelerated demyelination of peripheral nerves in mice deficient in connexin 32 and protein zero.
Neuberg DH; Carenini S; Schachner M; Martini R; Suter U
J Neurosci Res; 1998 Sep; 53(5):542-50. PubMed ID: 9726425
[TBL] [Abstract][Full Text] [Related]
40. Functional analysis of connexin-32 mutants associated with X-linked dominant Charcot-Marie-Tooth disease.
Wang HL; Chang WT; Yeh TH; Wu T; Chen MS; Wu CY
Neurobiol Dis; 2004 Mar; 15(2):361-70. PubMed ID: 15006706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
